Cosmetics & Personal Care | Monthly bulletin | June 2026
FDA approves bemotrizinol: are you ready for the next-gen sunscreens?
The FDA has officially added bemotrizinol to its list of aproved active ingredients in over-the-counter (OTC) sunscreens, marking the first new UV filter approval in over two decades. This decision opens the door to a new generation of high-performance sun protection products in the U.S. market.
Bemotrizinol is widely used across the globe and valued for its broad-spectrum protection against both ultraviolet A and B rays, as well as its photostability and formulation flexibility. The FDA has determined it to be generally recognised as safe and effective (GRASE) for use in sunscreen products for both adults and children of 6 months and older.
For brands looking to incorporate this ingredient into their formulations, the path to market readiness requires robust testing and validation to ensure regulatory confidence. Eurofins Cosmetics & Personal Care provides testing solutions to support you at every stage of product development, including:
- Active ingredient and formulation testing
- Stability studies
- Microbiological testing
- Method validation and regulatory preparation
- In vitro and clinical SPF and UV protection
Our team ensures your sunscreen products meet the latest standards and are fully prepared for a smooth and compliant market launch.
Let’s bring the next generation of sun care to the market, together.
From clinical data to visual impact
At Eurofins Cosmetics & Personal Care, we leverage a professional photo studio setup to elevate your clinical studies by turning efficacy results into high-impact visual assets. Beyond standard imaging, our approach combines scientific rigour with professional photography expertise, ensuring that every before/after image is captured under strictly controlled conditions—consistent lighting, standardised angles, defined posture and neutral backgrounds—to guarantee reliability and comparability.
Working with experienced photographers, we produce high-resolution, publication-quality visuals (up to 6000 x 4000 px, 300 dpi) that not only demonstrate real product performance but also meet the highest standards for communication and regulatory use. These are not just images taken during a study, they are carefully designed visual proofs built to highlight visible improvements with precision through multi-angle shots and targeted zooms on areas of interest.
These standardised before/after visuals can be seamlessly reused across platforms—advertising, digital, social media or scientific publications—without the need for additional photo shoots. With this innovative tool, you transcribe data into credible, compelling storytelling, equipping your brand with scientifically robust and professionally crafted assets that reinforce claims, accelerate consumer trust, and maximise the value of your clinical investment.
Menstrual underwear: are you ready for the 2026 regulatory requirements?
With the publication of Decree No. 2026-288 and its corresponding implementing notice, the regulatory landscape for menstrual underwear is entering a new phase, introducing both reimbursement opportunities and increasingly stringent requirements related to safety, performance, and durability.
To access the French National Health Insurance system, manufacturers must now provide robust, science-based evidence demonstrating product compliance under real-life conditions of use. This includes dermatological and gynecological assessments on adapted panels, validated by medical experts, alongside comprehensive performance testing covering absorption capacity, resistance to repeated washing cycles (up to 52), dimensional stability, material durability, colour fastness, and mechanical strength. Beyond compliance, these requirements represent a strategic opportunity to differentiate products from their competitors through objective, measurable proof of performance across the product lifecycle. Adapting to these new requirements early is key to anticipating listing conditions, securing market access, and aligning with regulatory expectations.
Eurofins Cosmetics & Personal Care supports manufacturers at every step, delivering the scientific data and testing strategies needed to ensure compliance and strengthen product positioning in this rapidly evolving market.
